Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Feb 5, 2026 (8 months ago)

thiamine HCl

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

thiamine HCl, 500 mg, 500 mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-079-56.

Affected NDC 71506-0079-56

Compare with the code on your package — it is the most precise check available.

Drug: Thiamine

Recalling firm
Fresenius Kabi Compounding, LLC
NDC code
71506-079-56
Origin
MA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0335-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Thiamine recalls

See all

Other recalls by Fresenius Kabi Compounding, LLC

All 2026 recalls